21 May 2026 | 03:00 PM GMT
Past Meeting

Predictive AI in Chronic Disease: Catching Deterioration Before the ER Visit

Participants:

Andrew Ibrahim Chief Clinical OfficerViz.AIHealth Tech & Solutions
Health Tech & Solutions
Andrew Ibrahim
Chief Clinical OfficerViz.AI
Paul Wicks Founder & Chief Evidence OfficerProofStack HealthProfessional Services
Professional Services
Paul Wicks
Founder & Chief Evidence OfficerProofStack Health
Alyson Stover Founding PartnerThrivynHealth System & Providers
Health System & Providers
Alyson Stover
Founding PartnerThrivyn
Beata Green CTODigitals for HealthHealth Tech & Solutions
Health Tech & Solutions
Beata Green
CTODigitals for Health
Bradley Fryer Sales DirectorHLTHHealth Tech & Solutions
Health Tech & Solutions
Bradley Fryer
Sales DirectorHLTH
CB
Carolina Bianco Technology and Science leadRocheHealth Tech & Solutions
CB
Health Tech & Solutions
Carolina Bianco
Technology and Science leadRoche
Chiazim Idris Infectious Diseases Resident PhysicianMatei Bals National Institute of Infectious DiseasesHealth System & Providers
Health System & Providers
Chiazim Idris
Infectious Diseases Resident PhysicianMatei Bals National Institute of Infectious Diseases
Douglas Runt Head of Digital InnovationZEISS Medical TechnologyHealth Tech & Solutions
Health Tech & Solutions
Douglas Runt
Head of Digital InnovationZEISS Medical Technology
Eddy Ang Chief Medical OfficerUCLA Health Medicare Advantage PlanPayer & Insurer
Payer & Insurer
Eddy Ang
Chief Medical OfficerUCLA Health Medicare Advantage Plan
Gilbert Semaan DH Franchise Lead, Neurology & ImmunologyMerck KGaA, GermanyLife Sciences, Pharma & Biotech
Life Sciences, Pharma & Biotech
Gilbert Semaan
DH Franchise Lead, Neurology & ImmunologyMerck KGaA, Germany
Ian Morrant GP Partner/Health Tech ConsultantThe Primary Care Innovation SpotlightProfessional Services
Professional Services
Ian Morrant
GP Partner/Health Tech ConsultantThe Primary Care Innovation Spotlight
Louise Nixon Program ManagerHLTHOther
Other
Louise Nixon
Program ManagerHLTH
MG
Maggie Gann Senior Project Manager- ClinicalQuest DiagnosticsHealth Tech & Solutions
MG
Health Tech & Solutions
Maggie Gann
Senior Project Manager- ClinicalQuest Diagnostics
Matt Norton VP of Marketing & Commercial DevelopmentS3 Connected HealthProfessional Services
Professional Services
Matt Norton
VP of Marketing & Commercial DevelopmentS3 Connected Health
Oisin Kim Chief Innovation Officer and Co-FounderMedihiveHealth Tech & Solutions
Health Tech & Solutions
Oisin Kim
Chief Innovation Officer and Co-FounderMedihive
Raghu Santhanam Owner, CEO, Managing PartnerVBC Advisor LLCProfessional Services
Professional Services
Raghu Santhanam
Owner, CEO, Managing PartnerVBC Advisor LLC
RA
Ruw Abeyratne Director of Health Equality and Inclusion University Hospitals of Leicester NHS Trust Health System & Providers
RA
Health System & Providers
Ruw Abeyratne
Director of Health Equality and Inclusion University Hospitals of Leicester NHS Trust

About this Meeting

Chronic disease management has long relied on reactive care, treating patients after exacerbations occur rather than preventing crises before they escalate. The promise of predictive AI is fundamentally different: identifying patients at risk of heart failure, COPD flare-ups, or diabetic emergencies sometimes days before acute events, creating intervention windows that can prevent hospitalizations entirely. The challenge lies in moving beyond predictions to actionable interventions, determining what care teams should do when AI flags high-risk patients, how to avoid alert fatigue when models generate hundreds of warnings, and whether prevented admissions translate to measurable financial and clinical returns.

This roundtable examines real-world implementations of predictive chronic disease AI that are demonstrating outcome improvements beyond pilot metrics. The discussion will address both the technical performance of predictive models and the care delivery redesign necessary to capture value from early warning systems.

Join us to discuss:

  • What predictive AI models are reliably identifying chronic disease exacerbations early enough to enable meaningful clinical intervention?

  • How are care teams operationalizing AI predictions - what specific interventions work when patients are flagged as high-risk but not yet symptomatic?

  • What ROI frameworks and outcome metrics demonstrate the value of prevented hospitalizations versus the costs of predictive AI infrastructure and intervention programs?

About Us

HLTH Inc. is a dynamic community delivering unique value to the healthcare industry through a mix of unparalleled global events, inspirational content, and impact-driven initiatives.

Hyve Logo

USA Event Dates

2026 | HLTH: Nov 15 – 18 | Las Vegas | Register | Sponsor
2027 | ViVE: Mar 14 – 17 | Nashville | Be First to Know | Sponsor
2027 | HLTH: Oct 17 – 20 | Las Vegas, NV

Europe Event Dates

2027 | HLTH Europe: Jun 21 – 24 | Amsterdam | Sponsor
2028 | HLTH Europe: Jun 19 – 22 | Amsterdam

Important Notice on Hotel Scams

Any communication that claims to represent HLTH or any third party offering discounted hotel rooms or attendee lists is NOT AFFILIATED with HLTH and should be considered fraudulent. Please book your accommodations only through HLTH’s official channels to ensure authenticity and security.